Understanding complex scientific studies is often a challenge for patients as well as healthcare professionals, but one that may become easier thanks to artificial intelligence. A new study has shown ...
Late last month, pharmaphorum was invited on an IDA Ireland-organised press tour of the life sciences industry in Ireland’s West, permitting an inside peek into the world-class life sciences ...
Alpibectir was developed in a public-private collaboration between GSK, Pasteur Institute Lille, and the University of Lille, and is designed as a companion to ethionamide (Eto), which is an important ...
Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regulators about the design of a ...
Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regulators about the design of a ...
The new study, published in Nature Medicine, reveals that almost all (95%) people with two copies of the ApoE4 variant have evidence of either Alzheimer’s pathology, like amyloid deposits in the brain ...
Pfizer will draw on the expertise of Citi analyst Andrew Baum when it comes to portfolio management and capital deployment, naming him chief strategy and innovation officer. The veteran biotech ...
Shah Capital is among the top three investors in Novavax, with a 7.5% stake that has swelled from 6.7% when it first launched its campaign against the company’s leadership last month. It had vowed to ...
The Novo Nordisk Foundation, the Bill & Melinda Gates Foundation, and Wellcome have joined forces to tackle some of the most ...
Boehringer Ingelheim says it may have found the first therapy for diabetic macular ischaemia (DMI), a common and irreversible ...
The Cancer Moonshot 2020 Initiative, announced in January of this year, is one of the biggest and most comprehensive collaborations to take on cancer ever launched. The $1 billion project aims to ...
In this article, Hardik Singhvi discusses the new trend in direct to patient selling by pharmaceutical companies, in order to reduce wastage and move manufacturers nearer to where the patients are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results